Cargando…
Protein tyrosine phosphatase receptor type Q in cerebrospinal fluid reflects ependymal cell dysfunction and is a potential biomarker for adult chronic hydrocephalus
BACKGROUND AND PURPOSE: Protein tyrosine phosphatase receptor type Q (PTPRQ) was extracted from the cerebrospinal fluid (CSF) of patients with probable idiopathic normal‐pressure hydrocephalus (iNPH) by proteome analysis. We aimed to assess the feasibility of using CSF PTPRQ concentrations for the a...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821334/ https://www.ncbi.nlm.nih.gov/pubmed/33035386 http://dx.doi.org/10.1111/ene.14575 |
_version_ | 1783639401675358208 |
---|---|
author | Nakajima, M. Rauramaa, T. Mäkinen, P. M. Hiltunen, M. Herukka, S.‐K. Kokki, M. Musialowicz, T. Jyrkkänen, H.‐K. Danner, N. Junkkari, A. Koivisto, A. M. Jääskeläinen, J. E. Miyajima, M. Ogino, I. Furuta, A. Akiba, C. Kawamura, K. Kamohara, C. Sugano, H. Tange, Y. Karagiozov, K. Leinonen, V. Arai, H. |
author_facet | Nakajima, M. Rauramaa, T. Mäkinen, P. M. Hiltunen, M. Herukka, S.‐K. Kokki, M. Musialowicz, T. Jyrkkänen, H.‐K. Danner, N. Junkkari, A. Koivisto, A. M. Jääskeläinen, J. E. Miyajima, M. Ogino, I. Furuta, A. Akiba, C. Kawamura, K. Kamohara, C. Sugano, H. Tange, Y. Karagiozov, K. Leinonen, V. Arai, H. |
author_sort | Nakajima, M. |
collection | PubMed |
description | BACKGROUND AND PURPOSE: Protein tyrosine phosphatase receptor type Q (PTPRQ) was extracted from the cerebrospinal fluid (CSF) of patients with probable idiopathic normal‐pressure hydrocephalus (iNPH) by proteome analysis. We aimed to assess the feasibility of using CSF PTPRQ concentrations for the additional diagnostic criterion of iNPH in Japanese and Finnish populations. METHODS: We compared PTPRQ concentrations among patients with probable iNPH and neurologically healthy individuals (normal control [NC] group), patients with normal‐pressure hydrocephalus (NPH) of acquired and congenital/developmental aetiologies, patients with Alzheimer’s disease and patients with Parkinson’s disease in a Japanese analysis cohort. A corresponding iNPH group and NC group in a Finnish cohort was used for validation. Patients in the Finnish cohort who underwent biopsy were classified into two groups based on amyloid and/or tau deposition. We measured PTPRQ expression levels in autopsied brain specimens of iNPH patients and the NC group. RESULTS: Cerebrospinal fluid PTPRQ concentrations in the patients with NPH of idiopathic, acquired and congenital/developmental aetiologies were significantly higher than those in the NC group and those with Parkinson’s disease, but iNPH showed no significant differences when compared with those in the Alzheimer’s disease group. For the patients with iNPH, the area under the receiver‐operating characteristic curve was 0.860 in the Japanese iNPH and 0.849 in the Finnish iNPH cohorts. Immunostaining and in situ hybridization revealed PTPRQ expression in the ependymal cells and choroid plexus. It is highly possible that the elevated PTPRQ levels in the CSF are related to ependymal dysfunction from ventricular expansion. CONCLUSIONS: Cerebrospinal fluid PTPRQ levels indicated the validity of this assay for auxiliary diagnosis of adult chronic hydrocephalus. |
format | Online Article Text |
id | pubmed-7821334 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78213342021-01-29 Protein tyrosine phosphatase receptor type Q in cerebrospinal fluid reflects ependymal cell dysfunction and is a potential biomarker for adult chronic hydrocephalus Nakajima, M. Rauramaa, T. Mäkinen, P. M. Hiltunen, M. Herukka, S.‐K. Kokki, M. Musialowicz, T. Jyrkkänen, H.‐K. Danner, N. Junkkari, A. Koivisto, A. M. Jääskeläinen, J. E. Miyajima, M. Ogino, I. Furuta, A. Akiba, C. Kawamura, K. Kamohara, C. Sugano, H. Tange, Y. Karagiozov, K. Leinonen, V. Arai, H. Eur J Neurol Dementia and Cognitive Disorders BACKGROUND AND PURPOSE: Protein tyrosine phosphatase receptor type Q (PTPRQ) was extracted from the cerebrospinal fluid (CSF) of patients with probable idiopathic normal‐pressure hydrocephalus (iNPH) by proteome analysis. We aimed to assess the feasibility of using CSF PTPRQ concentrations for the additional diagnostic criterion of iNPH in Japanese and Finnish populations. METHODS: We compared PTPRQ concentrations among patients with probable iNPH and neurologically healthy individuals (normal control [NC] group), patients with normal‐pressure hydrocephalus (NPH) of acquired and congenital/developmental aetiologies, patients with Alzheimer’s disease and patients with Parkinson’s disease in a Japanese analysis cohort. A corresponding iNPH group and NC group in a Finnish cohort was used for validation. Patients in the Finnish cohort who underwent biopsy were classified into two groups based on amyloid and/or tau deposition. We measured PTPRQ expression levels in autopsied brain specimens of iNPH patients and the NC group. RESULTS: Cerebrospinal fluid PTPRQ concentrations in the patients with NPH of idiopathic, acquired and congenital/developmental aetiologies were significantly higher than those in the NC group and those with Parkinson’s disease, but iNPH showed no significant differences when compared with those in the Alzheimer’s disease group. For the patients with iNPH, the area under the receiver‐operating characteristic curve was 0.860 in the Japanese iNPH and 0.849 in the Finnish iNPH cohorts. Immunostaining and in situ hybridization revealed PTPRQ expression in the ependymal cells and choroid plexus. It is highly possible that the elevated PTPRQ levels in the CSF are related to ependymal dysfunction from ventricular expansion. CONCLUSIONS: Cerebrospinal fluid PTPRQ levels indicated the validity of this assay for auxiliary diagnosis of adult chronic hydrocephalus. John Wiley and Sons Inc. 2020-11-01 2021-02 /pmc/articles/PMC7821334/ /pubmed/33035386 http://dx.doi.org/10.1111/ene.14575 Text en © 2020 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Dementia and Cognitive Disorders Nakajima, M. Rauramaa, T. Mäkinen, P. M. Hiltunen, M. Herukka, S.‐K. Kokki, M. Musialowicz, T. Jyrkkänen, H.‐K. Danner, N. Junkkari, A. Koivisto, A. M. Jääskeläinen, J. E. Miyajima, M. Ogino, I. Furuta, A. Akiba, C. Kawamura, K. Kamohara, C. Sugano, H. Tange, Y. Karagiozov, K. Leinonen, V. Arai, H. Protein tyrosine phosphatase receptor type Q in cerebrospinal fluid reflects ependymal cell dysfunction and is a potential biomarker for adult chronic hydrocephalus |
title | Protein tyrosine phosphatase receptor type Q in cerebrospinal fluid reflects ependymal cell dysfunction and is a potential biomarker for adult chronic hydrocephalus |
title_full | Protein tyrosine phosphatase receptor type Q in cerebrospinal fluid reflects ependymal cell dysfunction and is a potential biomarker for adult chronic hydrocephalus |
title_fullStr | Protein tyrosine phosphatase receptor type Q in cerebrospinal fluid reflects ependymal cell dysfunction and is a potential biomarker for adult chronic hydrocephalus |
title_full_unstemmed | Protein tyrosine phosphatase receptor type Q in cerebrospinal fluid reflects ependymal cell dysfunction and is a potential biomarker for adult chronic hydrocephalus |
title_short | Protein tyrosine phosphatase receptor type Q in cerebrospinal fluid reflects ependymal cell dysfunction and is a potential biomarker for adult chronic hydrocephalus |
title_sort | protein tyrosine phosphatase receptor type q in cerebrospinal fluid reflects ependymal cell dysfunction and is a potential biomarker for adult chronic hydrocephalus |
topic | Dementia and Cognitive Disorders |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821334/ https://www.ncbi.nlm.nih.gov/pubmed/33035386 http://dx.doi.org/10.1111/ene.14575 |
work_keys_str_mv | AT nakajimam proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus AT rauramaat proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus AT makinenpm proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus AT hiltunenm proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus AT herukkask proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus AT kokkim proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus AT musialowiczt proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus AT jyrkkanenhk proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus AT dannern proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus AT junkkaria proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus AT koivistoam proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus AT jaaskelainenje proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus AT miyajimam proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus AT oginoi proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus AT furutaa proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus AT akibac proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus AT kawamurak proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus AT kamoharac proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus AT suganoh proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus AT tangey proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus AT karagiozovk proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus AT leinonenv proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus AT araih proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus |